Angiodynamics, Inc. (ANGO) Tops Q2 EPS by 1c; Guides Q3, Q4, FY12 EPS and Revs

Angiodynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $53.4 million versus the consensus estimate of $56.26 million.

Angiodynamics, Inc. sees Q3 2012 EPS of $0.09-$0.11, versus the consensus of $0.11. Angiodynamics, Inc. sees Q3 2012 revenue of $52-$54 million, versus the consensus of $54.65 million.

Angiodynamics, Inc. sees Q4 2012 EPS of $0.11-$0.13. Angiodynamics, Inc. sees Q4 2012 revenue of $53.5-$55.5 million.

Angiodynamics, Inc. sees FY2012 EPS of $0.41-$0.45, versus the consensus of $0.44. Angiodynamics, Inc. sees FY2012 revenue of $218-$222 million, versus the consensus of $219.9 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Creative Medical Technology issues mid-year pipeline update
• AeroVironment (AVAV) Tops Q4 EPS by 36c